Skip to content

Web-based counseling for families with parental cancer: a randomized controlled intervention study

Web-based counseling for families with parental cancer: a randomized controlled intervention study - Famoca

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00006298
Enrollment
90
Registered
2014-07-03
Start date
2014-04-07
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psychological adaptation to parental cancer

Interventions

Group 1: Interventiongroup: web-based counseling for families with parental cancer during 16 weeks Group 2: control group: informations (brochures, leafletters, important adresses / numbers) about can

Sponsors

Universitätsspital Basel
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to No maximum

Inclusion criteria

Inclusion criteria: - First time diagnosis of any kind of cancer - expected progression free survival of 12 months - Married, cohabiting or single parent - At least one child between 3-18 years living with the parents - German speaking - Access to the internet - Basic computer skills

Exclusion criteria

Exclusion criteria: - Parent patients not living with their children - Parent patients without custody of their children

Design outcomes

Primary

MeasureTime frame
adjustment of children, questionnaires at baseline, T1 (+5 months), T2 (+ 12 months), KINDL

Secondary

MeasureTime frame
adjustment in couple (patient and partner) and in family, if it improves family communication and coping strategies, questionnaires at baseline, T1 (+ 5 months), T2 (+ 12 months), Brief-Cope, HADS, FACES, SDQ, PFB

Countries

Austria, Germany, Switzerland

Contacts

Public ContactVerena Ehrbar

Universitätsspital Basel, FrauenklinikGyn. Sozialmedizin und Psychosomatik

verena.ehrbar@usb.ch0041612659441

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026